GGrantIndex
← Leaderboards

Benjamin Landon Myer

Columbia University Health Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$8,501,100
Attributed
$20,912,686
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2012–24
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$20,912,686 · 6

By mechanism

R01$20,322,143 · 4
R21$590,543 · 2

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Woman”

Research focus

WomanSouth AfricaPregnancyPregnant WomenAntiretroviral TherapyPostpartum PeriodHiv InfectionsPregnantCohortPreventionEnrollmentTransmission ProcessHigh RiskPreventVertical Disease TransmissionNeonatalIn UteroAfricaMothersScale UpCountryPharmaceutical PreparationsChildMother-To-Child Hiv Transmission

Grant awards (24)

Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,452,419
R01 · FY2024 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,717,846
R01 · FY2023 · HD
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,491,998
R01 · FY2022 · HD
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)$470,258
R01 · FY2022 · MH
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,294,356
R01 · FY2021 · HD
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)$485,679
R01 · FY2021 · MH
Addressing the Dual Burden of HIV and non-communicable diseases in pregnancy in South Africa$175,312
R21 · FY2021 · TW
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)$2,382,926
R01 · FY2020 · HD
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)$488,179
R01 · FY2020 · MH
Addressing the Dual Burden of HIV and non-communicable diseases in pregnancy in South Africa$154,098
R21 · FY2020 · TW
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)$464,404
R01 · FY2019 · MH
Peer support to mitigate the impact of stigma in young HIV+ pregnant & postpartum women$130,428
R21 · FY2019 · TW · contact PI
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)$579,553
R01 · FY2018 · MH
Peer support to mitigate the impact of stigma in young HIV+ pregnant & postpartum women$130,705
R21 · FY2018 · TW · contact PI
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$507,979
R01 · FY2017 · HD
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$528,070
R01 · FY2016 · HD
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$98,566
R01 · FY2016 · HD
Strategies to optimize ART services for maternal&child health: the MCH-ART study$722,570
R01 · FY2014 · HD
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$508,321
R01 · FY2014 · HD
Strategies to optimize ART services for maternal&child health: the MCH-ART study$398,671
R01 · FY2014 · HD
Strategies to optimize ART services for maternal&child health: the MCH-ART study$963,966
R01 · FY2013 · HD
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$498,029
R01 · FY2013 · HD
Strategies to optimize ART services for maternal&child health: the MCH-ART study$789,907
R01 · FY2012 · HD
Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCT$478,446
R01 · FY2012 · HD